Summary
To determine whether hyperlipidemia affects the endothelium-dependent vasomotor response along the dilated vessel after percutaneous transluminal coronary angioplasty (PTCA), we evaluated 32 patients with one-vessel disease, 3–6 months after successful PTCA without restenosis. Fourteen patients had mild stenotic lesions not subjected to PTCA (non-PTCA sites) in addition to the PTCA sites. Vessel diameter changes at 32 PTCA and 36 non-PTCA sites were assessed by quantitative angiography, before and after intracoronary injection of acetylcholine (20µg to the right and 50µg to the left coronary artery) and of nitroglycerin (0.1–0.3mg). The acetylcholine response ranged from 46% (dilation) to −100% (constriction). All coronary arteries were dilated in response to nitroglycerin, which suggested preservation of the function of vascular smooth muscle, and the presence of an abnormality in endothelial function in those patients with a constrictor response to acetylcholine. There was a negative correlation between the acetylcholine response and the serum total cholesterol level at PTCA sites (r = −0.37;P = 0.038) and at non-PTCA sites (r = −0.46;P = 0.005). These findings indicate that hyperlipidemia is associated with a loss of endothelium-dependent vasodilation, not only at non-PTCA but also at PTCA sites, at which restoration of endothelial function might have occurred. They also suggest that hyperlipidemia may be related to the functional state of the regenerated endothelium at sites where PTCA had been previously performed.
Similar content being viewed by others
References
Bassenge E, Busse R (1988) Endothelial modulation of coronary tone. Prog Cardiovasc Dis 30:249–280
Furchgott RF (1983) Role of endothelium in responses of vascular smooth muscle. Circ Res 53:557–573
Vanhoutte PM (1988) The endothelium: Modulator of vascular smooth-muscle tone. N Engl J Med 319:349–380
Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P (1986) Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 315:1046–1051
Gage JE, Hess OM, Murakami T, Ritter M, Grimm J, Krayenbuehl HP (1986) Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: Reversibility by nitroglycerin. Circulation 73:865–876
Werns SW, Walton JA, Hsia HH, Nabel EG, Sanz ML, Pitt B (1989) Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease. Circulation 79:287–291
Yasue H, Matsuyama K, Matsuyama K, Okumura K, Morikami Y, Ogawa H (1990) Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Possible role of early coronary atherosclerosis. Circulation 81:482–490
Suter TM, Buechi M, Hess OM, Haemmerli-Saner C, Gaglione A, Krayenbuehl HP (1992) Normalization of coronary vasomotion after percutaneous transluminal coronary angioplasty? Circulation 85:86–92
Freiman PC, Mitchell GG, Heistad DD, Armstrong ML, Harrison DG (1986) Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates. Circ Res 58:783–789
Sellke FW, Armstrong ML, Harrison DG (1990) Endothelium-dependent vascular relaxation is abnormal in the coronary microcirculation of atherosclerotic primates. Circulation 81:1586–1593
Cooke JP, Andon NA, Girerd XJ, Hirsch AT, Creager MA (1991) Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta. Circulation 83:1057–1062
Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P (1990) Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 81:491–497
Leung WH, Lau CP, Wong CK (1993) Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet 341:1496–1500
Egashira K, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Inou T, Takeshita A (1994) Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation 89:2519–2524
Weidinger FF, McLenachan JM, Cybulsky MI, Gordon JB, Rennke HG, Hollenberg NK, Fallon JT, Gantz P, Cooke JP (1990) Persistent dysfunction of regenerated endothelium after balloon angioplasty of rabbit iliac artery. Circulation 81:1667–1679
El-Tamimi H, Davies GJ, Crea F, Maseri A (1993) Response of human coronary arteries to acetylcholine after injury by coronary angioplasty. J Am Coll Cardiol 21:1152–1157
Zeiher AM, Drexler H, Wollschlaeger H, Just H (1991) Modulation of coronary vasomotor tone in humans; progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 83:391–401
Rubanyi GM (1991) Reversal of hypercholesterolemia-induced endothelial dysfunction byl-arginine. Circulation 83:1118–1120
Ross R (1986) The pathogenesis of atherosclerosis. An update. N Engl J Med 314:488–500
Verheuren TJ, Jordaens FH, Zonnekeyn LL, Van Hove CE, Coene MO, Herman AG (1986) Effect of hypercholesterolemia on vascular reactivity in the rabbit. Circ Res 58:783–789
Shimokawa H, Vanhoutte PM (1989) Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and atherosclerosis. Circ Res 64:900–914
Lopez JAG, Armstrong ML, Harrison DG, Piegors DJ, Heistad DD (1989) Vascular responses to leukocyte products in atherosclerotic primates. Circ Res 65:1078–1086
Heistad DD, Armstrong ML, Marcus ML, Piegors DJ, Mark AL (1984) Augmented response to vasoconstrictor stimuli in hypercholesterolemic and atherosclerotic monkeys. Circ Res 54:711–718
Heistad DD, Mark AL, Marcus ML, Piegors DJ, Armstrong ML (1987) Dietary treatment of atherosclerosis abolishes hyperresponsiveness to serotonin: Implications for vasospasm. Circ Res 61:346–351
Lopez JAG, Armstrong ML, Brotherton AFA, Piegors DJ, Heistad DD (1991) Effects of atherosclerosis and regression on vascular responses to products of activated platelets in primates. Am J Physiol 260:1051–1056
Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarholm JC, Alexander RW (1995) Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 332:481–487
Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P (1995) The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 332:488–493
Blankenhorn DH, Nessim SA, Johnson RL, Sanmarco ME, Azen SP, Cashin-Hemphill L (1987) Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 257:3233–3240
Buchwald H, Varco RL, Matts JP, Long JM, Fitch LL, Campbell GS (1990) Effect of partial ileal bypass on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia: Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH). N Engl J Med 323:946–955
Brown G, Albers JJ, Fisher LD, Schaefer SM, Lin JT, Kaplan C, Zhao XQ, Bisson BD, Fitzpatrick VF, Dodge HT (1990) Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 323:1289–1298
Watts GF, Lewis B, Brunt JNH, Lewis ES, Coltart DJ, Smith LDR, Mann JI, Swan AV (1992) Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet 339:563–569
Brown BG, Zhao XQ, Sacco DE, Albers JJ (1993) Lipid lowering and plaque regression: New insights into prevention of plaque disruption and clinical events in coronary diseases. Circulation 87:1781–1791
AHA Committee Report (1975) A reporting system on patients evaluated for coronary artery disease. Circulation 51:7
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sakai, A., Hirayama, A., Adachi, T. et al. Is the Presence of Hyperlipidemia Associated with Impairment of Endothelium-Dependent Neointimal Relaxation After Percutaneous Transluminal Coronary Angioplasty?. Heart Vessels 11, 255–261 (1996). https://doi.org/10.1007/BF01746206
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01746206